U.S. regulators warned a leading marijuana company for making unproven health claims about CBD, the trendy ingredient that’s turning up in lotions, foods and pet treats.
The Food and Drug Administration announced Tuesday it warned Curaleaf Inc., of Wakefield, Massachusetts, for illegally selling unapproved products. Curaleaf’s claims could lead people to delay medical care for serious conditions like cancer, the agency said.
“Consumers should beware of purchasing or using any such products,” said acting FDA Commissioner Ned Sharpless in a statement.
The FDA has issued similar warning letters to smaller businesses, but this is the first since the agency began studying how it regulates CBD. The agency plans to report in the fall on its regulatory approach after holding a public hearing and receiving nearly 4,500 comments.
The agency is exploring “potential regulatory pathways” for some CBD products to be lawfully marketed, Sharpless said.
Curaleaf, which operates in 12 states, said it will work with the FDA to resolve the issues mentioned in the warning letter. The company’s shares fell more than 7% on the news, and some other cannabis stocks lost ground. [Read more at The Frederick News-Post]
Your email address will not be published. Required fields are marked *
Save my name, email, and website in this browser for the next time I comment.
Notify me of follow-up comments by email.
Notify me of new posts by email.
SANTA FE, N.M. (AP) — New Mexico regulators have doubled the number of marijuana plants that licensed growers can cultivate as the state prepares for recreational sales to start this spring, officials announced Tuesday. Increasing the plant count makes sense “to ensure that everyone can maximize the benefits of a thriving cannabis industry,” said state…
Thailand plans to decriminalize marijuana, moving a step closer to clearing its use for recreation, after becoming the first country in Southeast Asia to legalize medical cannabis and its use in food and cosmetics. The nation’s Food and Drug Administration is set to propose the removal of marijuana from a list of controlled drugs to…
For a moment, newly available medical marijuana flower was a hot commodity in Louisiana, drawing thousands of new patients and huge lines to the state’s nine authorized pharmacies. Then it was gone. Pharmacies across the state reported supply disruptions less than two weeks after flower became available at the start of 2022. And patients have…
THE French hemp and CBD industry is waiting for a court decision this week which it hopes will overturn the Government’s ban on the sale of CBD flowers – following hearings on two successive Fridays. On Friday gone, in the Palais-Royal in the centre of Paris, France’s highest court the Council of State listened to…